Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the HEP3B cell line

Yu-Jui Yvonne Wan, Yan Cai, Thomas R. Magee

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Retinoic acid (RA) up-regulates retinoic acid receptor β (RARβ) gene expression in a variety of cell lines. Whether up-regulation of the RARβ gene reflects increased activity in a RARβ-mediated biological process is unclear since RARβ tends to heterodimerize with retinoid x receptor (RXR). In F9 teratocarcinoma cell line, RA-induced differentiation is accompanied by increased expression of the RARE, RXRα, and α-fetoprotein (AFP) genes. Previously, we have shown that the RA-mediated regulation of the AFP gene is through RXRα homodimers. In contrast to F9 cells, Hep3B is unique in that the AFP gene is down-regulated by RA in a manner reminiscent of down- regulation of AFP in postfetal liver. In this paper, we have examined the RA- mediated regulation of the RAR, RXR, peroxisome proliferator-activated receptor (PPAR), and AFP genes in Hep3B cells. RA induced the expression of RARα, β, and γ mRNA in Hep3B cells. However, the expression of RXRα mRNA was down-regulated, and the levels of RXRβ and RXRγ mRNA remained unchanged after RA treatment. In addition, the expression of the PPARα, β, and γ genes was also unchanged. Gel retardation assays demonstrated that RA decreased the overall binding of nuclear receptors to the RA and PPAR response elements. By super-shift assays using specific anti-RAR and -RXR antibodies, RA treatment decreased the amount of RXRα while increasing the amount RARE bound to retinoic acid response element-DR1 (direct repeat with spacer of one nucleotide), indicating the levels of RAR/RXR heterodimer, RXR/RXR homodimer, or RAR/RAR homodimers were altered upon RA treatment of Hep3B cells. In addition, the RA-mediated reduction of RXRα in part results in down-regulation of the AFP gene. Our data indicates that RA exerts its effects by differentially regulating its own receptor gene expression.

Original languageEnglish (US)
Pages (from-to)241-247
Number of pages7
JournalExperimental Cell Research
Volume238
Issue number1
DOIs
StatePublished - Jan 10 1998

Fingerprint

Retinoic Acid Receptors
Retinoids
Tretinoin
Fetal Proteins
Cell Line
Peroxisome Proliferator-Activated Receptors
Genes
Response Elements
Messenger RNA
Up-Regulation
Down-Regulation
Teratocarcinoma
Biological Phenomena
Gene Expression
Nucleic Acid Repetitive Sequences
Electrophoretic Mobility Shift Assay
Cytoplasmic and Nuclear Receptors

ASJC Scopus subject areas

  • Cell Biology

Cite this

Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the HEP3B cell line. / Wan, Yu-Jui Yvonne; Cai, Yan; Magee, Thomas R.

In: Experimental Cell Research, Vol. 238, No. 1, 10.01.1998, p. 241-247.

Research output: Contribution to journalArticle

@article{d193258b8c6449ea9c8a9704fef44d91,
title = "Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the HEP3B cell line",
abstract = "Retinoic acid (RA) up-regulates retinoic acid receptor β (RARβ) gene expression in a variety of cell lines. Whether up-regulation of the RARβ gene reflects increased activity in a RARβ-mediated biological process is unclear since RARβ tends to heterodimerize with retinoid x receptor (RXR). In F9 teratocarcinoma cell line, RA-induced differentiation is accompanied by increased expression of the RARE, RXRα, and α-fetoprotein (AFP) genes. Previously, we have shown that the RA-mediated regulation of the AFP gene is through RXRα homodimers. In contrast to F9 cells, Hep3B is unique in that the AFP gene is down-regulated by RA in a manner reminiscent of down- regulation of AFP in postfetal liver. In this paper, we have examined the RA- mediated regulation of the RAR, RXR, peroxisome proliferator-activated receptor (PPAR), and AFP genes in Hep3B cells. RA induced the expression of RARα, β, and γ mRNA in Hep3B cells. However, the expression of RXRα mRNA was down-regulated, and the levels of RXRβ and RXRγ mRNA remained unchanged after RA treatment. In addition, the expression of the PPARα, β, and γ genes was also unchanged. Gel retardation assays demonstrated that RA decreased the overall binding of nuclear receptors to the RA and PPAR response elements. By super-shift assays using specific anti-RAR and -RXR antibodies, RA treatment decreased the amount of RXRα while increasing the amount RARE bound to retinoic acid response element-DR1 (direct repeat with spacer of one nucleotide), indicating the levels of RAR/RXR heterodimer, RXR/RXR homodimer, or RAR/RAR homodimers were altered upon RA treatment of Hep3B cells. In addition, the RA-mediated reduction of RXRα in part results in down-regulation of the AFP gene. Our data indicates that RA exerts its effects by differentially regulating its own receptor gene expression.",
author = "Wan, {Yu-Jui Yvonne} and Yan Cai and Magee, {Thomas R.}",
year = "1998",
month = "1",
day = "10",
doi = "10.1006/excr.1997.3851",
language = "English (US)",
volume = "238",
pages = "241--247",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the HEP3B cell line

AU - Wan, Yu-Jui Yvonne

AU - Cai, Yan

AU - Magee, Thomas R.

PY - 1998/1/10

Y1 - 1998/1/10

N2 - Retinoic acid (RA) up-regulates retinoic acid receptor β (RARβ) gene expression in a variety of cell lines. Whether up-regulation of the RARβ gene reflects increased activity in a RARβ-mediated biological process is unclear since RARβ tends to heterodimerize with retinoid x receptor (RXR). In F9 teratocarcinoma cell line, RA-induced differentiation is accompanied by increased expression of the RARE, RXRα, and α-fetoprotein (AFP) genes. Previously, we have shown that the RA-mediated regulation of the AFP gene is through RXRα homodimers. In contrast to F9 cells, Hep3B is unique in that the AFP gene is down-regulated by RA in a manner reminiscent of down- regulation of AFP in postfetal liver. In this paper, we have examined the RA- mediated regulation of the RAR, RXR, peroxisome proliferator-activated receptor (PPAR), and AFP genes in Hep3B cells. RA induced the expression of RARα, β, and γ mRNA in Hep3B cells. However, the expression of RXRα mRNA was down-regulated, and the levels of RXRβ and RXRγ mRNA remained unchanged after RA treatment. In addition, the expression of the PPARα, β, and γ genes was also unchanged. Gel retardation assays demonstrated that RA decreased the overall binding of nuclear receptors to the RA and PPAR response elements. By super-shift assays using specific anti-RAR and -RXR antibodies, RA treatment decreased the amount of RXRα while increasing the amount RARE bound to retinoic acid response element-DR1 (direct repeat with spacer of one nucleotide), indicating the levels of RAR/RXR heterodimer, RXR/RXR homodimer, or RAR/RAR homodimers were altered upon RA treatment of Hep3B cells. In addition, the RA-mediated reduction of RXRα in part results in down-regulation of the AFP gene. Our data indicates that RA exerts its effects by differentially regulating its own receptor gene expression.

AB - Retinoic acid (RA) up-regulates retinoic acid receptor β (RARβ) gene expression in a variety of cell lines. Whether up-regulation of the RARβ gene reflects increased activity in a RARβ-mediated biological process is unclear since RARβ tends to heterodimerize with retinoid x receptor (RXR). In F9 teratocarcinoma cell line, RA-induced differentiation is accompanied by increased expression of the RARE, RXRα, and α-fetoprotein (AFP) genes. Previously, we have shown that the RA-mediated regulation of the AFP gene is through RXRα homodimers. In contrast to F9 cells, Hep3B is unique in that the AFP gene is down-regulated by RA in a manner reminiscent of down- regulation of AFP in postfetal liver. In this paper, we have examined the RA- mediated regulation of the RAR, RXR, peroxisome proliferator-activated receptor (PPAR), and AFP genes in Hep3B cells. RA induced the expression of RARα, β, and γ mRNA in Hep3B cells. However, the expression of RXRα mRNA was down-regulated, and the levels of RXRβ and RXRγ mRNA remained unchanged after RA treatment. In addition, the expression of the PPARα, β, and γ genes was also unchanged. Gel retardation assays demonstrated that RA decreased the overall binding of nuclear receptors to the RA and PPAR response elements. By super-shift assays using specific anti-RAR and -RXR antibodies, RA treatment decreased the amount of RXRα while increasing the amount RARE bound to retinoic acid response element-DR1 (direct repeat with spacer of one nucleotide), indicating the levels of RAR/RXR heterodimer, RXR/RXR homodimer, or RAR/RAR homodimers were altered upon RA treatment of Hep3B cells. In addition, the RA-mediated reduction of RXRα in part results in down-regulation of the AFP gene. Our data indicates that RA exerts its effects by differentially regulating its own receptor gene expression.

UR - http://www.scopus.com/inward/record.url?scp=0031843771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031843771&partnerID=8YFLogxK

U2 - 10.1006/excr.1997.3851

DO - 10.1006/excr.1997.3851

M3 - Article

C2 - 9457077

AN - SCOPUS:0031843771

VL - 238

SP - 241

EP - 247

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 1

ER -